More SEC Filings
View Older Stories View Newer Stories-
Form SCHEDULE 13G Venu Holding Corp Filed by: Nantahala Capital Management, LLC
-
Form SCHEDULE 13G VYNE Therapeutics Inc. Filed by: Nantahala Capital Management, LLC
-
Form 3/A BeOne Medicines Ltd. For: Sep 27 Filed by: Sharp Shalini
-
Form 13F-HR Partners Value Investmen For: Mar 31
-
Form 13F-NT Coatue Cardinal Main For: Mar 31
-
Form 4 AMKOR TECHNOLOGY, INC. For: May 13 Filed by: Morse Robert Randolph
-
Form SCHEDULE 13G/A CyberArk Software Ltd. Filed by: Pentwater Capital Management LP
-
Form SCHEDULE 13G/A EGH Acquisition Corp. Filed by: TENOR CAPITAL MANAGEMENT Co., L.P.
-
Form SCHEDULE 13G KIORA PHARMACEUTICALS Filed by: Alyeska Investment Group, L.P.
-
Form SCHEDULE 13G/A Enliven Therapeutics, Filed by: Venrock Healthcare Capital Partners III, L.P.
-
Form SCHEDULE 13G Helix Acquisition Corp. Filed by: Nantahala Capital Management, LLC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 UBS AG
-
Form 4 ASSURANT, INC. For: May 14 Filed by: Rosenblum Jay
-
Form FWP BANK5 2026-5YR22 Filed by: WELLS FARGO COMMERCIAL MORTGAGE SECURITIES INC
-
Form SCHEDULE 13G/A IO Biotech, Inc. Filed by: Point72 Asset Management, L.P.
-
Form NT 10-Q Cosmos Health Inc. For: Mar 31
-
Form 424B2 UBS AG
-
Form 13F-HR Family Manage LLC For: Mar 31
-
Form D GS Finance Corp.
-
Form 10-Q Artisan Consumer Goods, For: Mar 31
-
Form 4 BeOne Medicines Ltd. For: May 13 Filed by: Lee Chan Henry
-
Form 4 AMKOR TECHNOLOGY, INC. For: May 13 Filed by: Liao Daniel JL
-
Form 13F-HR WESTPORT ASSET MANAGEMEN For: Mar 31
-
Form 13F-NT Coatue Opportunity Fund For: Mar 31
-
Form SCHEDULE 13G/A ZIPRECRUITER, INC. Filed by: DISCIPLINED GROWTH INVESTORS INC /MN
-
Form 4 NEWMONT Corp /DE/ For: May 13 Filed by: BOYCE GREGORY H
-
Form SCHEDULE 13G/A IMMUNIC, INC. Filed by: Alyeska Investment Group, L.P.
-
Form SCHEDULE 13G/A Gogo Inc. Filed by: Nantahala Capital Management, LLC
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form SCHEDULE 13G/A CoreWeave, Inc. Filed by: Venturo Brian M
-
Form NT 10-Q RELIABILITY INC For: Mar 31
-
Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form 4 H2O AMERICA For: May 13 Filed by: HANLEY MARY ANN
-
Form SCHEDULE 13G/A Surgery Partners, Inc. Filed by: Pentwater Capital Management LP
-
Form 144 Garrett Motion Inc. Filed by: NINIVAGGI DANIEL A
-
Form 4 TriSalus Life Sciences, For: May 14 Filed by: HICKS KERRY R
-
Form 4 MGP INGREDIENTS INC For: May 14 Filed by: Lowry Jennifer Elaine
-
Form 4 GMR Solutions Inc. For: May 13 Filed by: REED JAN STERN
-
Form 4 TriSalus Life Sciences, For: May 14 Filed by: Wahlstrom Mats
-
Form 4 TriSalus Life Sciences, For: May 14 Filed by: Gordon Gary B.
-
Form 13F-NT SPH Group LLC For: Mar 31
-
Form SCHEDULE 13G/A NeuroPace Inc Filed by: ORBIMED ADVISORS LLC
-
Form 4 TriSalus Life Sciences, For: May 14 Filed by: MATLIN DAVID J
-
Form 8-K MORGAN STANLEY For: May 14
-
Form SCHEDULE 13G/A Forte Biosciences, Inc. Filed by: ORBIMED ADVISORS LLC
-
Form 10-Q Infinite Eagle Acquisiti For: Mar 31
-
Form N-2/A abrdn World Healthcare
-
Form 424B2 DEUTSCHE BANK AKTIENGESE
-
Form SCHEDULE 13G/A Erasca, Inc. Filed by: Venrock Healthcare Capital Partners III, L.P.

